Endocrinology and Metabolism Clinics of North America

Papers
(The TQCC of Endocrinology and Metabolism Clinics of North America is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Dosimetry in Advanced Thyroid Cancer178
Copyright157
Precocious and Delayed Puberty Revisited104
Pathobiology of Metabolic-Associated Fatty Liver Disease98
Contributors65
Disorders of Calcium and Magnesium55
Hyperosmolar Hyperglycemic State43
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes37
Presentation and Care for Children with Peripheral Precocious Puberty31
The Gland Entrance31
Delayed Puberty Including Constitutional Delay30
The Interaction Between Sex and Thyroid Cancer Development and Management28
Lipid Disorders and Pregnancy27
Peer Support to Enhance Type 2 Diabetes Prevention Among African American and Latino Adults25
The Inherited Hypercholesterolemias24
Social Determinants of Health Screening in Type 1 Diabetes Management23
Contributors22
Contents21
Bone Health in Acromegaly20
Subclinical Hypothyroidism and Thyroid Autoimmunity in Pregnancy20
Forthcoming Issues20
Medical Therapies of Cushing’s Disease–Part 119
Bone Metabolism, Bone Mass, and Bone Structure During Pregnancy and Lactation17
Global Health Disparities in Childhood Rickets17
Nonalcoholic Fatty Liver Disease17
Copyright16
Update in Papillary Thyroid Cancer16
New and Emerging Therapies for Dyslipidemia16
Update on Endocrine Disorders During Pregnancy16
Disparities in the Diagnosis and Management of Polycystic Ovarian Syndrome in Adolescents16
Contents15
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence15
Perspectives on Prediabetes and Aging15
Contributors15
Building an Infrastructure to Address Racial Disparities in Treatment and Outcomes in Children with Type 1 Diabetes14
Intermittent Fasting14
Contents14
Metabolic-Associated Fatty Liver Disease and Diabetes13
Diagnosis, Treatment, and Outcomes of Males with Central Precocious Puberty13
Copyright12
What Is a Honeymoon in Type 1, Can It Go into Remission?12
Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician12
Lipid and Lipoprotein Metabolism11
Contents11
Contents11
Root Cause for Metabolic Syndrome and Type 2 Diabetes10
Quality of Life in Patients with Adrenal Insufficiency9
Advancing Obesity Medicine9
Type 1 Diabetes9
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota9
Nutrient-Stimulating Hormone-Based Therapies for Obesity9
Age-Associated Abnormalities of Water Homeostasis9
Endocrine Disorders During Pregnancy9
Type 1 Diabetes and Aging9
Metabolic-Associated Fatty Liver Disease9
Lipid Disorders and Metabolic-Associated Fatty Liver Disease8
Isolated Vaginal Bleeding Before the Onset of Puberty8
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease8
Remission with an Intervention8
Copyright8
Update in Adrenal Steroidogenesis and Congenital Adrenal Hyperplasia8
Treatment of Central Precocious Puberty with a Focus on Girls8
The Evolving Role of Radioactive Iodine in Thyroid Cancer Diagnosis and Treatment8
Diagnosis and Management of Adrenocortical Carcinoma7
An Update on Redifferentiation Therapy for Radioiodine Refractory Thyroid Cancer7
Growth Hormone and Aging7
Novel Imaging Modalities in the Evaluation of Patients with Pituitary Adenomas7
Forthcoming Issues7
Copyright7
Health Disparities and Disrupted Puberty in Males7
Dyslipidemia in Diabetes7
Patient-Reported Outcomes in Endocrine Diseases7
Copyright6
Sociodemographic Factors in Pituitary Adenomas6
Metabolic-Associated Fatty Liver Disease and Sarcopenia6
Racial and Ethnic Disparities in Metabolic Bone Disease6
Obesity and Aging6
Copyright6
Diabetes Remission6
Sex Hormones and Cardiovascular Disease in Relation to Menopause6
0.078761100769043